Our results suggest that cannabidiol may represent a promising new protective strategy against cisplatin-induced nephrotoxicity.
Our results suggest that CBD may have significant therapeutic benefits against diabetic complications and atherosclerosis.
Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.
We show that cannabidiol has anti-inflammatory effects in a murine model of acute lung injury.